Harmony Biosciences stock hits 52-week low at $26.26
NegativeFinancial Markets

Harmony Biosciences has seen its stock price drop to a 52-week low of $26.26, raising concerns among investors about the company's future performance. This decline could indicate underlying issues within the company or the broader market, making it a significant event for stakeholders to monitor closely.
— Curated by the World Pulse Now AI Editorial System